Osteoporosis Drug Approval Highlights AJPB Week in Review

5. FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment

The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.